Tag: Mobi-C

Zimmer Biomet Spine announces FDA approval of Mobi-C cervical disc labelling...

  Zimmer Biomet has announced that the US Food and Drug Administration (FDA) has approved an extension to the Mobi-C Cervical Disc labelling to include...

Three podium presentations demonstrate positive results for Zimmer Biomet’s Mobi-C

Results from three studies presented at the 2017 French Spine Society Congress (SFCR; June  1–3, Lille, France) have demonstrated the short and long-term safety,...

Zimmer Biomet’s Mobi-C now most widely covered artificial cervical disc in...

Zimmer Biomet’s Mobi-C cervical disc prosthesis has become the most widely covered device for one- and two-level cervical disc replacement by commercial health insurers...

Seven-year data find Zimmer Biomet’s Mobi-C statistically superior to ACDF

Zimmer Biomet has announced results of a seven-year outcomes study demonstrating statistical superiority of its Mobi-C cervical disc prosthesis vs two-level anterior cervical discectomy...